
Join to View Full Profile
710 Westwood PlzRoom 1240Los Angeles, CA 90095
Phone+1 310-825-6681
Fax+1 310-206-4733
Dr. Ebiana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Victoria Ebiana, MD is a Neurology specialist based in New York, NY. She completed her education in 2013 from Columbia University Vagelos College of Physicians and Surgeons. Dr. Ebiana has several high-value publications related to lung cancer and stroke, most notable being her study on extensive-Stage Small-Cell Lung Cancer published in Journal of Clinical Oncology, cited an impressive 324 times. Her research primarily revolves around treatments such as pembrolizumab for non-small cell lung cancer and the study of Ischemic Stroke in patients with Parry-Romberg syndrome.
Education & Training
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2013
Certifications & Licensure
- CA State Medical License 2015 - 2025
- NY State Medical License 2017 - 2019
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 8 citationsFirst-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.Miyako Satouchi, Kaname Nosaki, Toshiaki Takahashi, Kazuhiko Nakagawa, Keisuke Aoe
Cancer Science. 2021-12-01 - 52 citationsOutcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and ...Aaron S. Mansfield, Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled
JTO Clinical and Research Reports. 2021-08-01 - 14 citationsFirst-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.Miyako Satouchi, Kaname Nosaki, Toshiaki Takahashi, Kazuhiko Nakagawa, Keisuke Aoe
Cancer Science. 2020-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: